These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 9840913)

  • 1. Fludarabine-related hemolytic anemia in chronic lymphocytic leukemia and lymphoproliferative disorders.
    Taha HM; Narasihman P; Venkatesh L; Cawley M; Kaplan B
    Am J Hematol; 1998 Dec; 59(4):316. PubMed ID: 9840913
    [No Abstract]   [Full Text] [Related]  

  • 2. Autoimmune thrombocytopenia: a complication of fludarabine therapy in lymphoproliferative disorders.
    Leach M; Parsons RM; Reilly JT; Winfield DA
    Clin Lab Haematol; 2000 Jun; 22(3):175-8. PubMed ID: 10931169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Irreversible renal failure in a patient with chronic lymphocytic leukemia treated with fludarabine.
    Timuragaoglu A; Karadogan I; Undar L
    Ann Hematol; 1999 Feb; 78(2):109-10. PubMed ID: 10089031
    [No Abstract]   [Full Text] [Related]  

  • 4. Combined fludarabine and rituximab for low grade lymphoma and chronic lymphocytic leukemia.
    Savage DG; Cohen NS; Hesdorffer CS; Heitjan D; Oster MW; Garrett TJ; Bar M; del Prete S; March R; Lonberg M; Talbot S; Mears JG; Flamm M; Taub RN; Nichols G
    Leuk Lymphoma; 2003 Mar; 44(3):477-81. PubMed ID: 12688318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fludarabine and hemolytic anemia in chronic lymphocytic leukemia.
    Hamblin TJ; Orchard JA; Myint H; Oscier DG
    J Clin Oncol; 1998 Sep; 16(9):3209-10. PubMed ID: 9738600
    [No Abstract]   [Full Text] [Related]  

  • 6. [Drug-induced hemolytic anemia].
    Wautier JL; Rouger P
    Transfus Clin Biol; 2001 Aug; 8(4):377-80. PubMed ID: 11642029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fludarabine in the treatment of lymphoproliferative malignancies.
    Feldman EJ; Keating MJ
    Cancer Invest; 1993; 11(3):314-8. PubMed ID: 8485654
    [No Abstract]   [Full Text] [Related]  

  • 8. Therapy-related myelodysplastic syndrome/acute myeloid leukemia following fludarabine therapy for non-Hodgkin lymphoma and chronic lymphocytic leukemia in Thai patients.
    Niparuck P; Kanoksil W; Chuncharunee S; Boonsakan P; Ungkanont A; Angchaisuksiri P; Karntisaviwat K; Apilugsanachit A; Rerkamnuatchoke B; Jootar S; Nitiyanant P; Atichartakarn V
    Leuk Lymphoma; 2010 Nov; 51(11):2120-5. PubMed ID: 20846095
    [No Abstract]   [Full Text] [Related]  

  • 9. Fatal recurrence of autoimmune hemolytic anemia following pentostatin therapy in a patient with a history of fludarabine-associated hemolytic anemia.
    Byrd JC; Hertler AA; Weiss RB; Freiman J; Kweder SL; Diehl LF
    Ann Oncol; 1995 Mar; 6(3):300-1. PubMed ID: 7612497
    [No Abstract]   [Full Text] [Related]  

  • 10. Severe autoimmune hemolytic anemia in two patients treated with fludarabine for chronic lymphocytic leukemia.
    Bastion Y; Coiffier B; Dumontet C; Espinouse D; Bryon PA
    Ann Oncol; 1992 Feb; 3(2):171-2. PubMed ID: 1606091
    [No Abstract]   [Full Text] [Related]  

  • 11. Evans syndrome complicating fludarabine treatment for advanced B-CLL.
    Shvidel L; Shtarlid M; Klepfish A; Sigler E; Berrebi A
    Br J Haematol; 1997 Dec; 99(3):706. PubMed ID: 9401088
    [No Abstract]   [Full Text] [Related]  

  • 12. Fludarabine phosphate--looking forward.
    Cheson BD
    Semin Oncol; 1990 Oct; 17(5 Suppl 8):1-2. PubMed ID: 1699277
    [No Abstract]   [Full Text] [Related]  

  • 13. Fatal intravascular autoimmune hemolytic anemia after fludarabine treatment for chronic lymphocytic leukemia.
    Tertian G; Cartron J; Bayle C; Rudent A; Lambert T; Tchernia G
    Hematol Cell Ther; 1996 Aug; 38(4):359-60. PubMed ID: 8891729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Fludarabine in the treatment of chronic lymphocytic leukemia and other lymphoproliferative disorders].
    Pawelski S
    Acta Haematol Pol; 1995; 26(3):263-8. PubMed ID: 8525771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fludarabine phosphate: an effective therapy for lymphoid malignancies.
    Semin Oncol; 1990 Oct; 17(5 Suppl 8):1-78. PubMed ID: 1699278
    [No Abstract]   [Full Text] [Related]  

  • 16. [Selective aplasia of the red-cell series after fludarabine administration in a patient with chronic B-cell lymphatic leukemia].
    Antich Rojas J; Balaguer H; Cladera A
    Sangre (Barc); 1997 Jun; 42(3):254-6. PubMed ID: 9381277
    [No Abstract]   [Full Text] [Related]  

  • 17. [Ulcers in a patient with chronic lymphocytic leukemia].
    León-Mateos A; Sánchez-Aguilar D; Toribio J
    Actas Dermosifiliogr; 2007 May; 98(4):279-80. PubMed ID: 17506962
    [No Abstract]   [Full Text] [Related]  

  • 18. Fludarabine-induced autoimmune hemolytic anemia in a CLL patient: rituximab as the treatment of choice?
    Smolej L
    Leuk Res; 2007 Feb; 31(2):267; author reply 268-9. PubMed ID: 16716397
    [No Abstract]   [Full Text] [Related]  

  • 19. Severe autoimmune hemolytic anemia in a patient with chronic lymphocytic leukemia responsive to fludarabine-based treatment.
    Tosti S; Caruso R; D'Adamo F; Picardi A; Ali Ege M; Girelli G; Mauro FR; Maurillo L; Amadori S
    Ann Hematol; 1992 Nov; 65(5):238-9. PubMed ID: 1457584
    [No Abstract]   [Full Text] [Related]  

  • 20. Infections in patients with chronic lymphocytic leukemia treated with fludarabine.
    Anaissie EJ; Kontoyiannis DP; O'Brien S; Kantarjian H; Robertson L; Lerner S; Keating MJ
    Ann Intern Med; 1998 Oct; 129(7):559-66. PubMed ID: 9758577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.